- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Kotyark Bio Specialities Ltd, a subsidiary of Kotyark Industries Ltd, has received approval for the issuance of 12,60,000 (12.60 lakh) 0.01% Compulsory Convertible Debentures (CCDs) with a face value of ₹100 each, totaling ₹12.60 crores, through a private placement. As of January 7, 2025, subscriptions for 11,90,000 (11.90 lakh) CCDs have been confirmed, resulting in an allotment of ₹11.90 crores. The remaining CCDs will be allotted upon receipt of further subscriptions. This move could bolster the subsidiary’s financial position and enhance its growth prospects. Investors should watch closely for the potential impacts of the full subscription and conversion dynamics.